to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
This informative piece explains a well-known method that venture capitalists use to determine "post-money valuation," which is a company's valuation at the time of investment. Perhaps more important, it provides valuable insights into why the returns expected by investors are often perceived as "too high" by entrepreneurs.
In medical business news, a venture fund in Michigan has raised $15 million for investment in lifescience companies. SWMF LifeScience Venture Fund plans to raise $35 million more. Read more about this lifescience venture fund’s goals.
A new report says healthcare spending will make up 20 percent of the U.S. economy by 2019. Read more on what kind of companies can take advantage of the growing healthcare business market.
A Medical Industry Valuation Laboratory is becoming known beyond Minnesota, even in China. Using a multi-faceted approach, the lab evaluates medical technologies and determines whether they should be commercialized.
A healthcare business with a solution to the problem of catheter-related bloodstream infections is preparing to seek regulatory approvals for its product. Read more about this young company’s plans.
Wouldn’t every healthcare business entrepreneur like to have access to business experts and a connection to investors? These are two components of Minnesota Angel Network’s new program.
Late-stage deals don't have much value for one outspoken venture capitalist. Read more about the reasons for his claim.
Last week we launched a brand new program for startup companies who had previously presented at 1 Million Cups, the Kauffman Foundation's weekly educational program that features two local startups presenting to the community over coffee. This new effort, launched with the folks at Dream Big America, will continue to put a spotlight on startup companies from throughout the country.
Healthcare stocks are just what the doctor ordered when it comes to a tough economy – at least, that’s the opinion of one investment guru.
It’s no secret that the economy is in sickbay. But healthcare entrepreneurs looking for a big transfusion of cash shouldn’t look to an initial public offering.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.